APO Research

APO RESEARCH · REPORT

Topical Analgesics

Selected research

Market Structure

Global Topical Analgesics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

Market perspective

The global Topical Analgesics market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Topical Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Topical Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Topical Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Topical Analgesics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Topical Analgesics include Sanofi, Johnson & Johnson, Novartis, Mylan, GSK, Topical BioMedics, THE PURE SOURCE, Teikoku Seiyaku and Qizheng, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Topical Analgesics market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Topical Analgesics and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Topical Analgesics sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Topical Analgesics market size, projected growth trends, production technologies, key applications, and end-use industries.

Topical Analgesics Segment by Company

Sanofi

Johnson & Johnson

Novartis

Mylan

GSK

Topical BioMedics

THE PURE SOURCE

Teikoku Seiyaku

Qizheng

Mercury Healthcare

Lingrui

Huarun 999

Hisamitsu

Endo

Actavis

Topical Analgesics Segment by Type

Pain Relief Patches

Analgesic Creams

Analgesic Sprays

Topical Analgesics Segment by Application

Muscle Pain

Arthritis Pain

Topical Analgesics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topical Analgesics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Topical Analgesics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topical Analgesics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Topical Analgesics market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Topical Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Topical Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Topical Analgesics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Topical Analgesics Industry Trends Table 2. Topical Analgesics Industry Drivers Table 3. Topical Analgesics Industry Opportunities and Challenges Table 4. Topical Analgesics Industry Restraints Table 5. Global Topical Analgesics Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Topical Analgesics Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Topical Analgesics Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Topical Analgesics Sales Market Share by Manufacturers Table 9. Global Topical Analgesics Average Sales Price (US$/unit) of Manufacturers (2021-2026) Table 10. Global Topical Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Topical Analgesics Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Topical Analgesics Manufacturers, Product Type & Application Table 13. Global Topical Analgesics Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Topical Analgesics by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Pain Relief Patches Table 17. Major Manufacturers of Analgesic Creams Table 18. Major Manufacturers of Analgesic Sprays Table 19. Global Topical Analgesics Sales by Type 2021 VS 2025 VS 2032 (k units) Table 20. Global Topical Analgesics Sales by Type (2021-2026) & (k units) Table 21. Global Topical Analgesics Sales by Type (2027-2032) & (k units) Table 22. Global Topical Analgesics Sales Market Share by Type (2021-2026) Table 23. Global Topical Analgesics Sales Market Share by Type (2027-2032) Table 24. Global Topical Analgesics Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 25. Global Topical Analgesics Revenue by Type (2021-2026) & (k units) Table 26. Global Topical Analgesics Revenue by Type (2027-2032) & (k units) Table 27. Global Topical Analgesics Revenue Market Share by Type (2021-2026) Table 28. Global Topical Analgesics Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of Muscle Pain Table 30. Major Manufacturers of Arthritis Pain Table 31. Global Topical Analgesics Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Topical Analgesics Sales by Application (2021-2026) & (k units) Table 33. Global Topical Analgesics Sales by Application (2027-2032) & (k units) Table 34. Global Topical Analgesics Sales Market Share by Application (2021-2026) Table 35. Global Topical Analgesics Sales Market Share by Application (2027-2032) Table 36. Global Topical Analgesics Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Topical Analgesics Revenue by Application (2021-2026) & (k units) Table 38. Global Topical Analgesics Revenue by Application (2027-2032) & (k units) Table 39. Global Topical Analgesics Revenue Market Share by Application (2021-2026) Table 40. Global Topical Analgesics Revenue Market Share by Application (2027-2032) Table 41. Global Topical Analgesics Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Topical Analgesics Sales by Region (2021-2026) & (k units) Table 43. Global Topical Analgesics Sales Market Share by Region (2021-2026) Table 44. Global Topical Analgesics Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Topical Analgesics Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Topical Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Topical Analgesics Sales by Country (2021-2026) & (k units) Table 48. North America Topical Analgesics Sales by Country (2027-2032) & (k units) Table 49. Europe Topical Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Topical Analgesics Sales by Country (2021-2026) & (k units) Table 51. Europe Topical Analgesics Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Topical Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Topical Analgesics Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Topical Analgesics Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Topical Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Topical Analgesics Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Topical Analgesics Sales by Country (2027-2032) & (k units) Table 58. Global Topical Analgesics Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Topical Analgesics Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Topical Analgesics Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Topical Analgesics Revenue Market Share by Region (2021-2026) Table 62. Global Topical Analgesics Revenue Market Share by Region (2027-2032) Table 63. Sanofi Company Information Table 64. Sanofi Business Overview Table 65. Sanofi Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Sanofi Topical Analgesics Product Portfolio Table 67. Sanofi Recent Development Table 68. Johnson & Johnson Company Information Table 69. Johnson & Johnson Business Overview Table 70. Johnson & Johnson Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Johnson & Johnson Topical Analgesics Product Portfolio Table 72. Johnson & Johnson Recent Development Table 73. Novartis Company Information Table 74. Novartis Business Overview Table 75. Novartis Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Novartis Topical Analgesics Product Portfolio Table 77. Novartis Recent Development Table 78. Mylan Company Information Table 79. Mylan Business Overview Table 80. Mylan Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Mylan Topical Analgesics Product Portfolio Table 82. Mylan Recent Development Table 83. GSK Company Information Table 84. GSK Business Overview Table 85. GSK Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. GSK Topical Analgesics Product Portfolio Table 87. GSK Recent Development Table 88. Topical BioMedics Company Information Table 89. Topical BioMedics Business Overview Table 90. Topical BioMedics Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Topical BioMedics Topical Analgesics Product Portfolio Table 92. Topical BioMedics Recent Development Table 93. THE PURE SOURCE Company Information Table 94. THE PURE SOURCE Business Overview Table 95. THE PURE SOURCE Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. THE PURE SOURCE Topical Analgesics Product Portfolio Table 97. THE PURE SOURCE Recent Development Table 98. Teikoku Seiyaku Company Information Table 99. Teikoku Seiyaku Business Overview Table 100. Teikoku Seiyaku Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. Teikoku Seiyaku Topical Analgesics Product Portfolio Table 102. Teikoku Seiyaku Recent Development Table 103. Qizheng Company Information Table 104. Qizheng Business Overview Table 105. Qizheng Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. Qizheng Topical Analgesics Product Portfolio Table 107. Qizheng Recent Development Table 108. Mercury Healthcare Company Information Table 109. Mercury Healthcare Business Overview Table 110. Mercury Healthcare Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. Mercury Healthcare Topical Analgesics Product Portfolio Table 112. Mercury Healthcare Recent Development Table 113. Lingrui Company Information Table 114. Lingrui Business Overview Table 115. Lingrui Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. Lingrui Topical Analgesics Product Portfolio Table 117. Lingrui Recent Development Table 118. Huarun 999 Company Information Table 119. Huarun 999 Business Overview Table 120. Huarun 999 Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Huarun 999 Topical Analgesics Product Portfolio Table 122. Huarun 999 Recent Development Table 123. Hisamitsu Company Information Table 124. Hisamitsu Business Overview Table 125. Hisamitsu Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Hisamitsu Topical Analgesics Product Portfolio Table 127. Hisamitsu Recent Development Table 128. Endo Company Information Table 129. Endo Business Overview Table 130. Endo Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. Endo Topical Analgesics Product Portfolio Table 132. Endo Recent Development Table 133. Actavis Company Information Table 134. Actavis Business Overview Table 135. Actavis Topical Analgesics Sales (k units), Price (US$/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Actavis Topical Analgesics Product Portfolio Table 137. Actavis Recent Development Table 138. Key Raw Materials Table 139. Raw Materials Key Suppliers Table 140. Topical Analgesics Distributors List Table 141. Topical Analgesics Customers List Table 142. Research Programs/Design for This Report Table 143. Authors List of This Report Table 144. Secondary Sources Table 145. Primary Sources List of Figures Figure 1. Topical Analgesics Product Image Figure 2. Global Topical Analgesics Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Topical Analgesics Market Size (2021-2032) & (US$ Million) Figure 4. Global Topical Analgesics Sales (2021-2032) & (k units) Figure 5. Global Topical Analgesics Average Price (US$/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Topical Analgesics Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Pain Relief Patches Image Figure 9. Analgesic Creams Image Figure 10. Analgesic Sprays Image Figure 11. Global Topical Analgesics Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 12. Global Topical Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Topical Analgesics Sales Market Share by Type (2021-2032) Figure 14. Global Topical Analgesics Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 15. Global Topical Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Topical Analgesics Revenue Market Share by Type (2021-2032) Figure 17. Muscle Pain Image Figure 18. Arthritis Pain Image Figure 19. Global Topical Analgesics Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Topical Analgesics Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Topical Analgesics Sales Market Share by Application (2021-2032) Figure 22. Global Topical Analgesics Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Topical Analgesics Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Topical Analgesics Revenue Market Share by Application (2021-2032) Figure 25. North America Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Topical Analgesics Sales Market Share by Country (2021-2032) Figure 27. U.S. Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Topical Analgesics Sales Market Share by Country (2021-2032) Figure 32. Germany Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Topical Analgesics Sales Market Share by Country (2021-2032) Figure 39. China Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Topical Analgesics Sales Market Share by Country (2021-2032) Figure 47. Brazil Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Topical Analgesics Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Topical Analgesics Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Topical Analgesics Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Topical Analgesics Revenue (2021-2032) & (US$ Million) Figure 58. North America Topical Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Topical Analgesics Revenue (2021-2032) & (US$ Million) Figure 60. Europe Topical Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Topical Analgesics Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Topical Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Topical Analgesics Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Topical Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Topical Analgesics Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Topical Analgesics Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Pain Relief Patches
  • Analgesic Creams
  • Analgesic Sprays
Applications
  • Muscle Pain
  • Arthritis Pain
Companies covered
  • Sanofi
  • Johnson & Johnson
  • Novartis
  • Mylan
  • GSK
  • Topical BioMedics
  • THE PURE SOURCE
  • Teikoku Seiyaku
  • Qizheng
  • Mercury Healthcare
  • Lingrui
  • Huarun 999
  • Hisamitsu
  • Endo
  • Actavis

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Topical Analgesics Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Topical Analgesics Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Topical Analgesics Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Topical Analgesics Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Topical Analgesics Market Dynamics
  1. 2.1 Topical Analgesics Industry Trends
  2. 2.2 Topical Analgesics Industry Drivers
  3. 2.3 Topical Analgesics Industry Opportunities and Challenges
  4. 2.4 Topical Analgesics Industry Restraints
3 Topical Analgesics Market by Manufacturers
  1. 3.1 Global Topical Analgesics Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Topical Analgesics Sales by Manufacturers (2021-2026)
  3. 3.3 Global Topical Analgesics Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Topical Analgesics Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Topical Analgesics Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Topical Analgesics Manufacturers, Product Type & Application
  7. 3.7 Global Topical Analgesics Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Topical Analgesics Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Topical Analgesics Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Topical Analgesics Tier 1, Tier 2, and Tier 3
4 Topical Analgesics Market by Type
  1. 4.1 Topical Analgesics Type Introduction
  2. 4.1.1 Pain Relief Patches
  3. 4.1.2 Analgesic Creams
  4. 4.1.3 Analgesic Sprays
  5. 4.2 Global Topical Analgesics Sales by Type
  6. 4.2.1 Global Topical Analgesics Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Topical Analgesics Sales by Type (2021-2032)
  8. 4.2.3 Global Topical Analgesics Sales Market Share by Type (2021-2032)
  9. 4.3 Global Topical Analgesics Revenue by Type
  10. 4.3.1 Global Topical Analgesics Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Topical Analgesics Revenue by Type (2021-2032)
  12. 4.3.3 Global Topical Analgesics Revenue Market Share by Type (2021-2032)
5 Topical Analgesics Market by Application
  1. 5.1 Topical Analgesics Application Introduction
  2. 5.1.1 Muscle Pain
  3. 5.1.2 Arthritis Pain
  4. 5.2 Global Topical Analgesics Sales by Application
  5. 5.2.1 Global Topical Analgesics Sales by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Topical Analgesics Sales by Application (2021-2032)
  7. 5.2.3 Global Topical Analgesics Sales Market Share by Application (2021-2032)
  8. 5.3 Global Topical Analgesics Revenue by Application
  9. 5.3.1 Global Topical Analgesics Revenue by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Topical Analgesics Revenue by Application (2021-2032)
  11. 5.3.3 Global Topical Analgesics Revenue Market Share by Application (2021-2032)
6 Global Topical Analgesics Sales by Region
  1. 6.1 Global Topical Analgesics Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Topical Analgesics Sales by Region (2021-2032)
  3. 6.2.1 Global Topical Analgesics Sales by Region (2021-2026)
  4. 6.2.2 Global Topical Analgesics Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Topical Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Topical Analgesics Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Topical Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Topical Analgesics Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Topical Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Topical Analgesics Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Topical Analgesics Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Topical Analgesics Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Topical Analgesics Revenue by Region
  1. 7.1 Global Topical Analgesics Revenue by Region
  2. 7.1.1 Global Topical Analgesics Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Topical Analgesics Revenue by Region (2021-2026)
  4. 7.1.3 Global Topical Analgesics Revenue by Region (2027-2032)
  5. 7.1.4 Global Topical Analgesics Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Topical Analgesics Revenue (2021-2032)
  8. 7.2.2 North America Topical Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Topical Analgesics Revenue (2021-2032)
  11. 7.3.2 Europe Topical Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Topical Analgesics Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Topical Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Topical Analgesics Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Topical Analgesics Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Sanofi
  2. 8.1.1 Sanofi Company Information
  3. 8.1.2 Sanofi Business Overview
  4. 8.1.3 Sanofi Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Sanofi Topical Analgesics Product Portfolio
  6. 8.1.5 Sanofi Recent Developments
  7. 8.2 Johnson & Johnson
  8. 8.2.1 Johnson & Johnson Company Information
  9. 8.2.2 Johnson & Johnson Business Overview
  10. 8.2.3 Johnson & Johnson Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Johnson & Johnson Topical Analgesics Product Portfolio
  12. 8.2.5 Johnson & Johnson Recent Developments
  13. 8.3 Novartis
  14. 8.3.1 Novartis Company Information
  15. 8.3.2 Novartis Business Overview
  16. 8.3.3 Novartis Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Novartis Topical Analgesics Product Portfolio
  18. 8.3.5 Novartis Recent Developments
  19. 8.4 Mylan
  20. 8.4.1 Mylan Company Information
  21. 8.4.2 Mylan Business Overview
  22. 8.4.3 Mylan Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Mylan Topical Analgesics Product Portfolio
  24. 8.4.5 Mylan Recent Developments
  25. 8.5 GSK
  26. 8.5.1 GSK Company Information
  27. 8.5.2 GSK Business Overview
  28. 8.5.3 GSK Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GSK Topical Analgesics Product Portfolio
  30. 8.5.5 GSK Recent Developments
  31. 8.6 Topical BioMedics
  32. 8.6.1 Topical BioMedics Company Information
  33. 8.6.2 Topical BioMedics Business Overview
  34. 8.6.3 Topical BioMedics Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Topical BioMedics Topical Analgesics Product Portfolio
  36. 8.6.5 Topical BioMedics Recent Developments
  37. 8.7 THE PURE SOURCE
  38. 8.7.1 THE PURE SOURCE Company Information
  39. 8.7.2 THE PURE SOURCE Business Overview
  40. 8.7.3 THE PURE SOURCE Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 THE PURE SOURCE Topical Analgesics Product Portfolio
  42. 8.7.5 THE PURE SOURCE Recent Developments
  43. 8.8 Teikoku Seiyaku
  44. 8.8.1 Teikoku Seiyaku Company Information
  45. 8.8.2 Teikoku Seiyaku Business Overview
  46. 8.8.3 Teikoku Seiyaku Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Teikoku Seiyaku Topical Analgesics Product Portfolio
  48. 8.8.5 Teikoku Seiyaku Recent Developments
  49. 8.9 Qizheng
  50. 8.9.1 Qizheng Company Information
  51. 8.9.2 Qizheng Business Overview
  52. 8.9.3 Qizheng Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Qizheng Topical Analgesics Product Portfolio
  54. 8.9.5 Qizheng Recent Developments
  55. 8.10 Mercury Healthcare
  56. 8.10.1 Mercury Healthcare Company Information
  57. 8.10.2 Mercury Healthcare Business Overview
  58. 8.10.3 Mercury Healthcare Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Mercury Healthcare Topical Analgesics Product Portfolio
  60. 8.10.5 Mercury Healthcare Recent Developments
  61. 8.11 Lingrui
  62. 8.11.1 Lingrui Company Information
  63. 8.11.2 Lingrui Business Overview
  64. 8.11.3 Lingrui Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Lingrui Topical Analgesics Product Portfolio
  66. 8.11.5 Lingrui Recent Developments
  67. 8.12 Huarun 999
  68. 8.12.1 Huarun 999 Company Information
  69. 8.12.2 Huarun 999 Business Overview
  70. 8.12.3 Huarun 999 Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Huarun 999 Topical Analgesics Product Portfolio
  72. 8.12.5 Huarun 999 Recent Developments
  73. 8.13 Hisamitsu
  74. 8.13.1 Hisamitsu Company Information
  75. 8.13.2 Hisamitsu Business Overview
  76. 8.13.3 Hisamitsu Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hisamitsu Topical Analgesics Product Portfolio
  78. 8.13.5 Hisamitsu Recent Developments
  79. 8.14 Endo
  80. 8.14.1 Endo Company Information
  81. 8.14.2 Endo Business Overview
  82. 8.14.3 Endo Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Endo Topical Analgesics Product Portfolio
  84. 8.14.5 Endo Recent Developments
  85. 8.15 Actavis
  86. 8.15.1 Actavis Company Information
  87. 8.15.2 Actavis Business Overview
  88. 8.15.3 Actavis Topical Analgesics Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Actavis Topical Analgesics Product Portfolio
  90. 8.15.5 Actavis Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Topical Analgesics Value Chain Analysis
  2. 9.1.1 Topical Analgesics Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Topical Analgesics Production Mode & Process
  6. 9.2 Topical Analgesics Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Topical Analgesics Distributors
  9. 9.2.3 Topical Analgesics Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research